Glaukos Corp
A California eye-care company making tiny implants and dropless treatments for glaucoma and other eye conditions, its signature iStent is a micro-sized device placed in the eye to lower pressure. Founded in 1998, it pioneered micro-invasive glaucoma surgery with the first human implant of its stent in 2001. The name comes from ancient Greek "glaukos," meaning gleaming or blue-gray—the same root as the word "glaucoma."
Estimated from filings — the split-adjusted price range over the quarters each manager built the position. A range, not a fill price; 13F reports a quarter-end snapshot, not a trade date.